{"ticker": {"uuid": "573219fe-d0f3-4388-9604-c11b2a1ef8ae", "symbol": "BOLD", "name": "Boundless Bio, Inc. Common Stock", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Jim Cramer just revealed his \u2018favorite stock\u2019", "summary": "", "url": "https://news.google.com/rss/articles/CBMic0FVX3lxTE1NdFRfaFBkMkJaaldyOUloclhWNDF2NVBZLVRTRnZxbnY0NVNsdmZyNk90RENjUzEwR2wyZUlpSDV4ZTEzaURrTGN4U0s5d09PRENXVTBGSFRZNGRsS2o5dlhPMXZSUUZDeVZ5QTloakVhN0E?oc=5", "source_name": "Finbold", "published_at": "2026-07-16T10:24:01+00:00", "published_display": "16 Jul 2026 10:24", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here\u2019s how much SpaceX stock crashed below its IPO price", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxQa0RINEFmNkpaQkdmLV9XQXdRU3F3QkJpcWdTOVZXSGRvUWx1dkpvWHF0cGRqSEFFZ0Y1Q0YtNnR0a0liSXBzUU56Z1NTV3FWT0xVSW1CS1ZVLUZzTUo1MWhWWVRuU0lTeExyQ1pRckFCb2lUZ3pET0t4ZjhCbjRlQWhn?oc=5", "source_name": "Finbold", "published_at": "2026-07-16T09:42:57+00:00", "published_display": "16 Jul 2026 09:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AEHR Stock Rockets After Earnings Beat And Bold 2027 Outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOcElUVW9xSWtiOUwwdW5KWUVCMExqUU9zVUhhT05lTkt4alJKWEF2Q3VZYW1RRGFIRlFHX2p1S3JHWHFTREhDRHVNOGlhMlRfY01LNGNJSjhXSDlMeXpCZjNUcFVaaHFIeEk4V2toelo2eXhWZ3I1TXFjclJRWDBkYQ?oc=5", "source_name": "timothysykes.com", "published_at": "2026-07-15T18:33:00+00:00", "published_display": "15 Jul 2026 18:33", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AEHR Stock Surges As Bold FY27 Guidance Electrifies Traders", "summary": "", "url": "https://news.google.com/rss/articles/CBMifEFVX3lxTE5kNUZjSTViV0plc1B6b2VOQ2VSU0RzZ1RMQ3MwRzBHUG4tMjRrQ2RZZnRCbnNUUHhUY0hwS1BLNnRxQXp1OE1zcVQ0djUwSW96QWtReU5fbUF0M3RNaTl5cmdMZDhFdE5kNFBXQzFaOWphT3hrR1kzVndoZVQ?oc=5", "source_name": "StocksToTrade", "published_at": "2026-07-15T16:33:00+00:00", "published_display": "15 Jul 2026 16:33", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tang capital management, Kevin Tang buy $222k Boundless Bio stock", "summary": "Tang Capital Management LLC and its manager Kevin Tang recently acquired $222,069 worth of Boundless Bio, Inc. (NASDAQ:BOLD) common stock between July 9 and July 13, 2026. These purchases involved 91,585 shares and increased their total beneficial ownership to 2,790,103 shares. T", "url": "https://www.investing.com/news/insider-trading-news/tang-capital-management-kevin-tang-buy-222k-boundless-bio-stock-93CH-4789587", "source_name": "Investing.com", "published_at": "2026-07-14T02:47:28", "published_display": "14 Jul 2026 02:47", "sentiment": "positive", "sentiment_pct": 60, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tang capital management, Kevin Tang buy $222k Boundless Bio stock By Investing.com", "summary": "Tang Capital Management LLC and its sole manager, Kevin Tang, have purchased $222,069 worth of Boundless Bio (NASDAQ:BOLD) common stock between July 9 and July 13, 2026. This acquisition involved 91,585 shares at weighted-average prices ranging from $2.42 to $2.48, increasing Tan", "url": "https://ng.investing.com/news/stock-market-news/tang-capital-management-kevin-tang-buy-222k-boundless-bio-stock-93CH-2597755", "source_name": "Investing.com Nigeria", "published_at": "2026-07-14T00:39:59", "published_display": "14 Jul 2026 00:39", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Boundless Bio Inc For: 13 July By Investing.com", "summary": "This article from Investing.com reports the filing of a Form 4 for Boundless Bio Inc. for July 13. The brief announcement provides no specific details from the Form 4 itself but mentions that the company's stock symbol is BOLD, which was down 0.82% at the time of publication.", "url": "https://ng.investing.com/news/stock-market-news/form-4-boundless-bio-inc-for-13-july-93CH-2597757", "source_name": "Investing.com Nigeria", "published_at": "2026-07-14T00:16:00", "published_display": "14 Jul 2026 00:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Teleflex Incorporated (TFX) Stock Analysis: Unpacking a 32.3% Revenue Growth in the Healthcare Sector", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxPQ3B5MlVsTlBhcXdmUVllazV2SWFHTmRudHVNdFY3RUYtR1FTXzNIV1VYODF0bTMyVThkOE1LZC11TGN2dUxBZzRPTDQxUDVDdF9PWW5VUk1rZVJkdXRjbTQ2MU1wa3BtejZ5NUhWY1dQLUZLS3duak1fMzIxcnNwUmc4X3N5Q1JXMFNQY1J0ZVd5aHF4NHVUQkpnNlNUU1VWcVljNjhGbkFicUNyOXktR0lZWkVxT09oU0VQZnZObG5RMkJDWHh4czRrUktNZFNrZVhKWnF1YTZ2ZmVzTG14WG1n?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-07-13T09:24:17+00:00", "published_display": "13 Jul 2026 09:24", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAJBVV95cUxPV1hqSFhQM3VfYlNsdldfeVQ1dEdNNzI3S1RTaFJNSThrOXlPSWpMTlR5WWVxNnNsTzhTVGVvTE94R18wa1A0OUdFczBlcTIzeUFBZUt6VVJJMjNqNks3dmRUSzB4cE40anpNekJwUXAwcTFEcVh4QVZCYURXY2w4b2thdk5KZ3ZJMnI1REJObXo5UDdISXVCU1Z2ZVZoVmJpbnEzaDVWVmpGQVNFZzRXYnp0SWRRWWZGSnZnWlJ4aEloNmJBNGRMVFRjb3ZRbmV3QXF5S0pvTV9xNnpaMWV1Z1ZtM3lPdV9RcEdURHlfZFphdjlicEJndW0ybHNBa205?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-07-13T03:32:00+00:00", "published_display": "13 Jul 2026 03:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Goldman Sachs Just Made 4 Bold Calls: 2 Sells, 1 Buy, and a $2,159 Price Target On This Popular Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxNY0oxb0FPcWtTZ241c3B5bllDRnpTeGpMZEZsMFJVcHpSd1VIYTdMbWpURkRIeXgyLWt4RjJ6aTY4Rm5md2ZmTDFVZ3FSb1hqV0RpNElEaUphTFF4a0MxYTJLeFNTbW5iUjhBZ2tOSjJuNjBLSzhuRC1wcERUblNmOEg4dE1HQ1k1RElOUzVmeEFVWGg5ekFDR0JjVDdETm8xdi1fbWFSQmc1ekx3LU5vWTU5RDMxUFU1aFVoX1ZQNGlDNktyLS1kWENCTEVTZWlETlBZRkQ1TQ?oc=5", "source_name": "24/7 Wall St.", "published_at": "2026-07-11T04:02:16+00:00", "published_display": "11 Jul 2026 04:02", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This solar stock could surge 80% on bold plan to turn your home into an AI data center, says Wells Fargo", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxQVTZvUUZWNVF6NlFXbFp4UWJNdE82NmVZM2I0bHg3ZTNQX256clZrZFZJNk5FYVg4MFB4MHdHWWQyOHJkRGxwNHEyNXN1eWNBRzFlN0ltREpWZFY3R1dPeWF5cjRLeGtWLTVtTGZ1M1k1YkRhYVNyblNZYkwyUHdndHdxSDBLMUpOY1B1aTQ0T3pPTXdTenVR?oc=5", "source_name": "CNBC", "published_at": "2026-07-09T18:21:39+00:00", "published_display": "09 Jul 2026 18:21", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "My Bold Prediction for This Stock Through 2030", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNUnVfQXBpRVNwOWxPaFNOU2x5NHBJUlhBYjVBMkRSUWxIWWtCY2s0LWNUMzNDR205Mzl4MDNJUG9CTks5ODFmWEgyZmVFd1pXM0lad1R6VkVtZElYNzRhMDNRMkpnc0lJWmx6Q3dTYkxTdzJKWVQySmJVSXMyWDQ5aEo1MzRtajdvYTlIcVl2VjVVSEZa?oc=5", "source_name": "24/7 Wall St.", "published_at": "2026-07-09T17:00:17+00:00", "published_display": "09 Jul 2026 17:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ten percent owner of Boundless Bio (NASDAQ: BOLD) adds shares", "summary": "Entities associated with Tang Capital Partners, a ten percent owner of Boundless Bio (NASDAQ: BOLD), purchased a total of 57,210 shares of common stock through open-market transactions between July 6 and July 8, 2026. These shares were bought at weighted-average prices ranging fr", "url": "https://www.stocktitan.net/sec-filings/BOLD/form-4-boundless-bio-inc-insider-trading-activity-8bb28b30217d.html", "source_name": "Stock Titan", "published_at": "2026-07-09T01:10:24", "published_display": "09 Jul 2026 01:10", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kevin Tang\u2019s Tang Capital buys $141,864 in Boundless Bio (BOLD) By Investing.com", "summary": "Kevin Tang and Tang Capital Management LLC increased their investment in Boundless Bio (NASDAQ:BOLD) by purchasing $141,864 worth of shares between July 6 and July 8, 2026. These transactions occurred as Boundless Bio's stock has seen a significant surge, despite an InvestingPro ", "url": "https://ca.investing.com/news/stock-market-news/kevin-tangs-tang-capital-buys-141864-in-boundless-bio-bold-93CH-4726272", "source_name": "Investing.com Canada", "published_at": "2026-07-09T00:13:02", "published_display": "09 Jul 2026 00:13", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Texas Instruments Stock Is Running On A Bold Promise", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxNNl9ZaEgyU1dlOGJ6THFxX2JtWlZRS1h2WEtCcDZ2UmR3dmpHUEtCcmt0aVA2WHl6bFBlSkpSOW9uaUhPTVdHRm1vM2tzckxCRjc0RGtGcndKem5VRDBvWmlydkZDVXM4a3VENjlqcTZhNVVXbzkzVzFRRGdQVkItVUVkVWpGQm1NX1Rqb01ieEE2aXhQdDdEa2MzTUh5MkJ5QjBSQWF1VG4zYzNIR1lyOWtR?oc=5", "source_name": "Trefis", "published_at": "2026-07-08T07:00:00+00:00", "published_display": "08 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Boundless Bio Inc For: 6 July By Investing.com", "summary": "This article from Investing.com announces the filing of Form 4 for Boundless Bio Inc for July 6th. Form 4 is a document that must be filed with the U.S. Securities and Exchange Commission (SEC) by company insiders, such as officers, directors, and significant shareholders, within", "url": "https://ca.investing.com/news/stock-market-news/form-4-boundless-bio-inc-for-6-july-93CH-4721859", "source_name": "Investing.com Canada", "published_at": "2026-07-06T22:11:15", "published_display": "06 Jul 2026 22:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ARCH funds, insiders trade 16,000 Boundless Bio (BOLD) shares", "summary": "Entities associated with ARCH Venture funds and investment committee member Kristina Burow conducted insider trading activities involving Boundless Bio (BOLD) shares. On July 1, 2026, 16,000 shares were acquired through a cashless stock option exercise at $1.03 per share and subs", "url": "https://www.stocktitan.net/sec-filings/BOLD/form-4-boundless-bio-inc-insider-trading-activity-a7effd86f512.html", "source_name": "Stock Titan", "published_at": "2026-07-06T22:11:14", "published_display": "06 Jul 2026 22:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arch venture funds sell $39,840 in Boundless Bio stock", "summary": "Several ARCH Venture Funds and Partners entities sold 16,000 shares of Boundless Bio, Inc. (NASDAQ:BOLD) common stock for $39,840 on July 1, 2026. This transaction followed a cashless exercise of stock options, with the shares acquired at $1.03 and immediately sold at $2.49. The ", "url": "https://www.investing.com/news/insider-trading-news/arch-venture-funds-sell-39840-in-boundless-bio-stock-93CH-4777779", "source_name": "Investing.com", "published_at": "2026-07-06T22:11:14", "published_display": "06 Jul 2026 22:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "16K Boundless Bio (BOLD) shares sold by ARCH funds post-exercise", "summary": "ARCH-affiliated entities reported a cashless stock option exercise and subsequent sale of 16,000 Boundless Bio (BOLD) shares. The transaction, tied to director Kristina Burow's compensation, involved exercising options at $1.03 per share and selling the shares at $2.49 per share.", "url": "https://www.stocktitan.net/sec-filings/BOLD/form-4-boundless-bio-inc-insider-trading-activity-6b853a676322.html", "source_name": "Stock Titan", "published_at": "2026-07-06T22:11:14", "published_display": "06 Jul 2026 22:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of: Element Solutions Inc. (NYSE \u2013 ESI), Boundless Bio Inc. (Nasdaq \u2013 BOLD), Nuvalent, Inc. (Nasdaq \u2013 NUVL), Dana Incorporated (NYSE \u2013 DAN)", "summary": "Brodsky & Smith LLC is investigating the proposed acquisitions of Element Solutions Inc. (NYSE \u2013 ESI), Boundless Bio Inc. (Nasdaq \u2013 BOLD), Nuvalent, Inc. (Nasdaq \u2013 NUVL), and Dana Incorporated (NYSE \u2013 DAN). The law firm reminds investors that there is no cost or financial obligat", "url": "https://www.globenewswire.com/news-release/2026/07/06/3322626/0/en/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-element-solutions-inc-nyse-esi-boundless-bio-inc-nasdaq-bold-nuvalent-inc-nasdaq-nuvl-dana-inco.html", "source_name": "GlobeNewswire", "published_at": "2026-07-06T16:11:14", "published_display": "06 Jul 2026 16:11", "sentiment": "negative", "sentiment_pct": 33, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TANG CAPITAL MANAGEMENT LLC Acquires Significant Stake in Boundl", "summary": "TANG CAPITAL MANAGEMENT LLC has acquired 2,533,845 shares of Boundless Bio Inc (NASDAQ: BOLD) for $2.60 per share, establishing a 0.33% position in the biotechnology company. Boundless Bio Inc is a clinical-stage oncology company developing cancer therapeutics targeting extrachro", "url": "https://www.gurufocus.com/news/8944626/tang-capital-management-llc-acquires-significant-stake-in-boundless-bio-inc", "source_name": "GuruFocus", "published_at": "2026-07-04T01:09:21", "published_display": "04 Jul 2026 01:09", "sentiment": "positive", "sentiment_pct": 64, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Boundless Bio Inc For: 2 July By Investing.com", "summary": "This article from Investing.com is a standard financial news brief announcing a \"Form 4\" filing for Boundless Bio Inc. dated July 2nd. It does not provide further details about the filing but is presented within a typical Investing.com layout, including market data and related ne", "url": "https://uk.investing.com/news/stock-market-news/form-4-boundless-bio-inc-for-2-july-93CH-4756062", "source_name": "Investing.com UK", "published_at": "2026-07-03T11:10:45", "published_display": "03 Jul 2026 11:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kevin Tang buys $268,880 of Boundless Bio (NASDAQ:BOLD) shares By Investing.com", "summary": "Kevin Tang and Tang Capital Management LLC, significant owners of Boundless Bio (NASDAQ:BOLD), acquired common stock worth $268,880 through various transactions between June 30 and July 2, 2026. These purchases occurred at weighted-average prices ranging from $2.49 to $2.54, as t", "url": "https://m.za.investing.com/news/stock-market-news/kevin-tang-buys-268880-of-boundless-bio-nasdaqbold-shares-93CH-4354980?ampMode=1", "source_name": "Investing.com South Africa", "published_at": "2026-07-03T00:39:34", "published_display": "03 Jul 2026 00:39", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Boundless Bio (BOLD) major holder buys 107,463 Common shares", "summary": "Entities affiliated with Kevin Tang, a major holder in Boundless Bio (BOLD), purchased 107,463 shares of common stock through open-market transactions between June 30 and July 2, 2026. The purchases were made at prices ranging from $2.49 to $2.60 per share, increasing their total", "url": "https://www.stocktitan.net/sec-filings/BOLD/form-4-boundless-bio-inc-insider-trading-activity-d430b16ea5af.html", "source_name": "Stock Titan", "published_at": "2026-07-02T23:39:34", "published_display": "02 Jul 2026 23:39", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tang Capital entities disclose 2.25M Boundless Bio (BOLD) shares in Form 3 filing", "summary": "Entities affiliated with Tang Capital, managed by Kevin Tang, have disclosed an initial beneficial ownership of 2,247,512 shares of Boundless Bio (BOLD) common stock. This information was revealed in a Form 3 filing, which serves as an initial statement of ownership rather than a", "url": "https://www.stocktitan.net/sec-filings/BOLD/form-3-boundless-bio-inc-initial-statement-of-beneficial-ownership-ef28833a944b.html", "source_name": "Stock Titan", "published_at": "2026-06-30T21:40:22", "published_display": "30 Jun 2026 21:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tang Capital Management acquires $714,768 of Boundless Bio stock", "summary": "Tang Capital Management LLC and its manager, Kevin Tang, acquired 286,333 shares of Boundless Bio (NASDAQ:BOLD) common stock worth $714,768 between June 25 and June 29, 2026. These transactions, at prices ranging from $2.47 to $2.56 per share, increase their total indirect owners", "url": "https://www.investing.com/news/insider-trading-news/tang-capital-management-acquires-714768-of-boundless-bio-stock-93CH-4766743", "source_name": "Investing.com", "published_at": "2026-06-30T10:09:43", "published_display": "30 Jun 2026 10:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tang Capital-affiliated funds boost Boundless Bio (BOLD) stake with 286K-share buy", "summary": "Funds affiliated with Tang Capital increased their stake in Boundless Bio (BOLD) by purchasing 286,333 shares between June 25-29, 2026. These open-market purchases were made at weighted-average prices generally ranging from $2.40 to $2.60 per share, through various Tang Capital l", "url": "https://www.stocktitan.net/sec-filings/BOLD/form-4-boundless-bio-inc-insider-trading-activity-b74456645899.html", "source_name": "Stock Titan", "published_at": "2026-06-30T00:10:40", "published_display": "30 Jun 2026 00:10", "sentiment": "positive", "sentiment_pct": 72, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tang Capital Management acquires $714,768 of Boundless Bio stock By Investing.com", "summary": "Tang Capital Management LLC, led by Kevin Tang, recently acquired 286,333 shares of Boundless Bio (NASDAQ: BOLD) common stock for $714,768 through multiple transactions between June 25 and June 29, 2026. These purchases were made at prices ranging from $2.47 to $2.56 per share, i", "url": "https://m.za.investing.com/news/stock-market-news/tang-capital-management-acquires-714768-of-boundless-bio-stock-93CH-4348868?ampMode=1", "source_name": "Investing.com South Africa", "published_at": "2026-06-30T00:10:40", "published_display": "30 Jun 2026 00:10", "sentiment": "positive", "sentiment_pct": 62, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tang-linked entities report 11.3% stake in Boundless Bio (NASDAQ: BOLD)", "summary": "A Schedule 13G filing reveals that Tang Capital Management, Kevin Tang, and affiliated entities collectively beneficially own 11.3% of Boundless Bio (NASDAQ: BOLD), representing 2,533,845 shares. This passive investment indicates shared voting and dispositive power among the invo", "url": "https://www.stocktitan.net/sec-filings/BOLD/schedule-13g-boundless-bio-inc-passive-investment-disclosure-5-655d03c9ccae.html", "source_name": "Stock Titan", "published_at": "2026-06-30T00:10:40", "published_display": "30 Jun 2026 00:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Boundless Bio Inc For: 29 June By Investing.com", "summary": "This article from Investing.com reports the filing of a Form 4 for Boundless Bio Inc. dated June 29. It provides no further details beyond the title and a stock symbol (BOLD) with a slight price drop. The content primarily consists of market data and unrelated news headlines.", "url": "https://za.investing.com/news/stock-market-news/form-4-boundless-bio-inc-for-29-june-93CH-4348871", "source_name": "Investing.com South Africa", "published_at": "2026-06-30T00:10:40", "published_display": "30 Jun 2026 00:10", "sentiment": "negative", "sentiment_pct": 40, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Boundless Bio, Inc. \u2013 NASDAQ:BOLD", "summary": "The article provides financial information for Boundless Bio, Inc. (NASDAQ: BOLD), specifically focusing on its enterprise value to revenue forward metric. It appears to be a financial data page from TradingView, offering an overview of the company's financials, news, and technic", "url": "https://www.tradingview.com/symbols/NASDAQ-BOLD/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-29T17:10:29", "published_display": "29 Jun 2026 17:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Boundless Bio, Inc. \u2013 NASDAQ:BOLD", "summary": "This article provides the forward price-to-sales ratio for Boundless Bio, Inc. (NASDAQ: BOLD), as listed on TradingView. It indicates that the NASDAQ market was closed at the time the data was presented, with no trades reported. The content is primarily a data point surrounded by", "url": "https://www.tradingview.com/symbols/NASDAQ-BOLD/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-29T06:41:56", "published_display": "29 Jun 2026 06:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Boundless Bio, Inc. \u2013 NASDAQ:BOLD", "summary": "This article focuses on the enterprise value to EBITDA forward for Boundless Bio, Inc. (NASDAQ: BOLD). It appears to be a placeholder or a stub page from TradingView, indicating financial data for the company. The page structure suggests it's part of a larger financial data servi", "url": "https://www.tradingview.com/symbols/NASDAQ-BOLD/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T13:39:55", "published_display": "28 Jun 2026 13:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Serapha Bio, Inc. entered into a definitive merger agreement to acquire Boundless Bio, Inc. in a reverse merger transaction.", "summary": "Serapha Bio, Inc. has entered into a definitive merger agreement to acquire Boundless Bio, Inc. in a reverse merger transaction. This deal will result in Serapha equity holders owning approximately 96.31% of the combined company, with Boundless Bio equity holders retaining 3.69%.", "url": "https://www.marketscreener.com/news/serapha-bio-inc-entered-into-a-definitive-merger-agreement-to-acquire-boundless-bio-inc-in-a-rev-ce7f5fdbdb8ef020", "source_name": "www.marketscreener.com", "published_at": "2026-06-26T22:40:52", "published_display": "26 Jun 2026 22:40", "sentiment": "positive", "sentiment_pct": 67, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BOLD Stock Alert: Halper Sadeh LLC is Investigating Whether Boundless Bio, Inc. is Obtaining a Fair Price for its Shareholders", "summary": "Halper Sadeh LLC, an investor rights law firm, is investigating the proposed merger of Boundless Bio, Inc. (NASDAQ: BOLD) with Serapha Bio, Inc. The firm is examining whether Boundless Bio shareholders are receiving a fair price, as they are expected to own only about 3.7% of the", "url": "https://www.marketscreener.com/news/bold-stock-alert-halper-sadeh-llc-is-investigating-whether-boundless-bio-inc-is-obtaining-a-fair-ce7f5fdad18df12d", "source_name": "marketscreener.com", "published_at": "2026-06-26T22:40:52", "published_display": "26 Jun 2026 22:40", "sentiment": "negative", "sentiment_pct": 36, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Boundless Bio Inc. Actuals & Estimates (NASDAQ:BOLD)", "summary": "This article provides an overview of Boundless Bio, Inc. (NASDAQ: BOLD), detailing its financial actuals and estimates, stock performance, and analyst forecasts. It covers the current stock price, historical highs and lows, market capitalization, upcoming earnings reports, and te", "url": "https://www.tradingview.com/symbols/NASDAQ-BOLD/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T20:40:20", "published_display": "26 Jun 2026 20:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BOLD Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides an overview of Boundless Bio, Inc. (BOLD) stock, including its current price, price target, analyst ratings, and financial performance. It highlights that analysts have a maximum price target of $4.00 for the stock, and the company has shown significant pric", "url": "https://www.tradingview.com/symbols/NASDAQ-BOLD/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T06:39:40", "published_display": "26 Jun 2026 06:39", "sentiment": "positive", "sentiment_pct": 70, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Are TECH, APGE, BOLD, REFI Obtaining Fair Deals for their Shareholders?", "summary": "Halper Sadeh LLC, an investor rights law firm, is investigating several companies\u2014Bio-Techne Corporation (TECH), Apogee Therapeutics, Inc. (APGE), Boundless Bio, Inc. (BOLD), and Chicago Atlantic Real Estate Finance, Inc. (REFI)\u2014for potential violations of federal securities laws", "url": "https://www.tradingview.com/news/prnewswire:764921ceb76dc:0-are-tech-apge-bold-refi-obtaining-fair-deals-for-their-shareholders/", "source_name": "TradingView", "published_at": "2026-06-25T18:09:58", "published_display": "25 Jun 2026 18:09", "sentiment": "negative", "sentiment_pct": 30, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Boundless Bio, Serapha Bio Sign Merger Deal With $230 Million Private Placement", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/boundless-bio-serapha-bio-sign-115841859.html", "source_name": "MT Newswires", "published_at": "2026-06-23T11:58:41+00:00", "published_display": "23 Jun 2026 11:58", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BOLD Stock Is Up 90% \u2014 Here's What's Behind The Biggest Rally In Company History", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxPNGExYlpRZDZkRkxEbWNMUjFmZ0VocGV3cERwcnFRSW92RFYwOEZxb0tSTXdkRzZMbWwzbGRlckdDRmJ1bUNjRjJPZFNBTXZsZ1IzR3hQdTlrNU41OFBDRU1SUlZxNWZhNnV4WlY3RE1YQVgzbGFNVWNSSTZyaEhFdHY0SHp0cWRMMmVEYnc2VHR0YUEwTUZ4RmpJZ0w?oc=5", "source_name": "Stocktwits", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Boundless Bio and Serapha Bio Announce Merger Agreement and $230 Million Concurrent Private Placement", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Manila Times", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Boundless Bio to Merge with Serapha Bio, Restructure Operations", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOV2RhTFpQX25Qa2NTY3hBMkxfakVMOWxiY1hGbUVpaFY3MXptcEZzLVNXWF91OFVkWG5pQ2tXODlKbmNnN3Z4eWE3RC1Gbk1KMGp0T29sd28ydi10MUVGSll3SlR0Y054clZOa25VUjl5LVplaDkzd3ZWRXJKbENaTGJSMngyMzRDRV9na1hNekxpazdZR3BobnlMMkZxNUdKMkdiME1FQWhGNWNIRHNkSExRczA?oc=5", "source_name": "TipRanks", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Macy's Stock Outlook Improves as Bold New Chapter Gains Traction", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxQZklheFN5ZF9LMEw4T1hOcEd2cDRTeEdkYkl4S05HMXZnSFNrUFVYYTA4cl9vV3N6MUFnREphcGNuV3JBNUtuVzRpRlZJV1BJeDVENlJPbDNfRVAxcUlNejF2X0l3cE04NnpLTVR6aUlkVjN1MXNKMnQ5ZVctbU92SmtsTUY2XzB1S2d6UTAxN25SZmdabEtFcUdOLXdPOG8?oc=5", "source_name": "Market source", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[8-K] Boundless Bio, Inc. Reports Material Event", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxOSTNaN2J1RnQtS0VJZHR3TzdFaEhodGhfckpxMTdlcXZKVnR1MjVuR3FGQWxfay1nMjBfM0NiU2dTUlhWNUN0c3FwZGQzbklwOVk1aTM0RFVuRXZfZDRJTnNobDhLcFBSQ0hnM1UwbFNyNDd5aGM3Z0lsVEhNT2NnZFJoUjNycDJtdHpndG5kSHJ5OHNhQ19jWWQyR3JrR19xcEE5UzNMSjRMQQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology Stock Rises 19% in 3 Months: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQM0ExNm9zZVBVMzB2cTFsYkhQeDJyeUV5Y1lSdWdsa2V2STFTSFBkYVlrRDJaUmE0bjZVLUxmZEh1UkFPbndtdWVDWmJBcEJaSmpTSlN4RkFkdF9EYkhFUXh3YWxqREkxRllfRXE0bFVuSkMwaExFNmk0UmNoa2R2NmQyb0p1N2pudENMMGMwWmVGT0J5SUxfeE5hT2hpUms1NHR4NzY1VWpNQVFYUWJkUnN3?oc=5", "source_name": "TradingView", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UNH stock jumps on Q1 earnings beat and raised guidance to $18.25+", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPTEprdzNMNGZxdkg5Wll5MTlvS1dheXQybm14TERTcGVzcHQzY0llOEpTa0dpZ1hGdHVyNWZ2cFFiWmZRdkl1aUp4YVlTMVJxSDRzaEdzRFB1cW93QzdhSmNxcEZDMWhGX2F0ODJFcjY1Mk1kMVhLNnVJSUhVMHZpRjRtTHo2cXBvbVJ3a05SWlJNMUdrSzFPbA?oc=5", "source_name": "eciks.org", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "eBay Stock Reaches New All-Time Highs Following Ryan Cohen's Bold Comment - EPS Miss Report", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxQZmFrSU42aXpoYnZFeWVEc091a3JkeHZGbFBoZ3lQOC04MmYtUjN5NEkxQXVkWFFqaDIwN3VSQVFhRFlDUWU0dVFNa3JrNmpVbmZCazZqWEZVRVQ5UFgwTzEzUzYtTFVHcW1JVngtZEtFUmI0X2o0clRaMmNWdE5GTEo1Q3drMWpMU2puTjJZUThmRW9xTjlqUjNNQmQ2N3R6VlZUbEFKem5UUHFSUmRrOWlZSzh1dw?oc=5", "source_name": "lwvtexas.org", "published_at": "2026-05-17T07:00:00+00:00", "published_display": "17 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "PDS BIOTECHNOLOGY ($PDSB) Releases Q1 2026 Earnings | PDSB Stock News", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxOcEdqLWM1SmVuNHpvZ2poNU5mOFppaWNtUi1IQVRHTmgxLUpyZHdUSDRnekdzMmVFQzFzUGo2RjlYenpCaTlfcUZhMm1yTzRwWUxnM01WY0libmxIVXNSM3RtMGxMY2RURTdMVW96bGU0SGZXRkE2SnVQdVNNUWw5RWtJQVJMX2pQQnRBRHBKMlRCUDct?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Boundless Bio Reports First Quarter 2026 Financial Results and Business Highlights", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/boundless-bio-reports-first-quarter-110000504.html", "source_name": "GlobeNewswire", "published_at": "2026-05-08T11:00:00+00:00", "published_display": "08 May 2026 11:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GE HealthCare (NASDAQ:GEHC) Posts Better-Than-Expected Sales In Q1 CY2026 But Stock Drops", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxOUjRRb0hlcHlOazlmelFaVVJSQWNnRmExZVBEQW1HMmVLTjNyU3d4WElsU05hdGlfYWFSY0twMTNWOVVCY0h4U2dYQ19BQl9pa3o0NWNBLW50WmFsSEVHdmJFV3JabnN5MFZpUWZabjZzY2tjMUtxbndONm9DS3NxTUp3Qjg2dWZnMDR2NXZ2eU80MWhSODVKdVgxZVJ6TWs3RFpCaDFqMXVtVkhmRVlOcWtqYUV1X1FPcGpfdERhRmwzdkZDaWxtSnJnd25Oam4yTnFHTFBkZi0tM1BZdkE?oc=5", "source_name": "StockStory", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Abbott is the most oversold healthcare stock as Q1 earnings roll on (XLV:NYSEARCA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOc2thQjFpazgwaFRfS3NjVXhlTkdFWHNFb240S0Z6akFtQXFIMmFmaXZnQ1A3OFVCQW9DT25OLVBQdGN5Yk52Mk9yUFlSX19ZS3FRTjZoR05zc2FVc25pVHQ0TDVHT2JmVnJabGNCREdLT2stV0IzLVdHWXpFZGU3V1NnVGhYbFRzNURVek41TVRmLWZQZTFYUkc4aXM0a1cwTkNFYTBfVnQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology Stock Declines More Than 9% in a Month: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxNTTJZRVF4TFNBb3BhMW9VUnBnMVZhenZLNlZJY3Ryc3pGZ3dhZXBDY3pId0I5NFdmVTdiR2EyNXNBZFFuQ1M2M3pUTlRZdXJkbGxaT29mWm4wTG5fU2RtV1hIZWRwZUVNb3BEbTZKX3NPRV9mZVpiY3JBZDdMSDRveW1Jb0lIVmRKLVlidA?oc=5", "source_name": "Market source", "published_at": "2026-03-18T07:00:00+00:00", "published_display": "18 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Jim Cramer just revealed his \u2018favorite stock\u2019", "summary": "", "url": "https://news.google.com/rss/articles/CBMic0FVX3lxTE1NdFRfaFBkMkJaaldyOUloclhWNDF2NVBZLVRTRnZxbnY0NVNsdmZyNk90RENjUzEwR2wyZUlpSDV4ZTEzaURrTGN4U0s5d09PRENXVTBGSFRZNGRsS2o5dlhPMXZSUUZDeVZ5QTloakVhN0E?oc=5", "source_name": "Finbold", "published_at": "2026-07-16T10:24:01+00:00", "published_display": "16 Jul 2026 10:24", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here\u2019s how much SpaceX stock crashed below its IPO price", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxQa0RINEFmNkpaQkdmLV9XQXdRU3F3QkJpcWdTOVZXSGRvUWx1dkpvWHF0cGRqSEFFZ0Y1Q0YtNnR0a0liSXBzUU56Z1NTV3FWT0xVSW1CS1ZVLUZzTUo1MWhWWVRuU0lTeExyQ1pRckFCb2lUZ3pET0t4ZjhCbjRlQWhn?oc=5", "source_name": "Finbold", "published_at": "2026-07-16T09:42:57+00:00", "published_display": "16 Jul 2026 09:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AEHR Stock Rockets After Earnings Beat And Bold 2027 Outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOcElUVW9xSWtiOUwwdW5KWUVCMExqUU9zVUhhT05lTkt4alJKWEF2Q3VZYW1RRGFIRlFHX2p1S3JHWHFTREhDRHVNOGlhMlRfY01LNGNJSjhXSDlMeXpCZjNUcFVaaHFIeEk4V2toelo2eXhWZ3I1TXFjclJRWDBkYQ?oc=5", "source_name": "timothysykes.com", "published_at": "2026-07-15T18:33:00+00:00", "published_display": "15 Jul 2026 18:33", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AEHR Stock Surges As Bold FY27 Guidance Electrifies Traders", "summary": "", "url": "https://news.google.com/rss/articles/CBMifEFVX3lxTE5kNUZjSTViV0plc1B6b2VOQ2VSU0RzZ1RMQ3MwRzBHUG4tMjRrQ2RZZnRCbnNUUHhUY0hwS1BLNnRxQXp1OE1zcVQ0djUwSW96QWtReU5fbUF0M3RNaTl5cmdMZDhFdE5kNFBXQzFaOWphT3hrR1kzVndoZVQ?oc=5", "source_name": "StocksToTrade", "published_at": "2026-07-15T16:33:00+00:00", "published_display": "15 Jul 2026 16:33", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tang capital management, Kevin Tang buy $222k Boundless Bio stock", "summary": "Tang Capital Management LLC and its manager Kevin Tang recently acquired $222,069 worth of Boundless Bio, Inc. (NASDAQ:BOLD) common stock between July 9 and July 13, 2026. These purchases involved 91,585 shares and increased their total beneficial ownership to 2,790,103 shares. T", "url": "https://www.investing.com/news/insider-trading-news/tang-capital-management-kevin-tang-buy-222k-boundless-bio-stock-93CH-4789587", "source_name": "Investing.com", "published_at": "2026-07-14T02:47:28", "published_display": "14 Jul 2026 02:47", "sentiment": "positive", "sentiment_pct": 60, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tang capital management, Kevin Tang buy $222k Boundless Bio stock By Investing.com", "summary": "Tang Capital Management LLC and its sole manager, Kevin Tang, have purchased $222,069 worth of Boundless Bio (NASDAQ:BOLD) common stock between July 9 and July 13, 2026. This acquisition involved 91,585 shares at weighted-average prices ranging from $2.42 to $2.48, increasing Tan", "url": "https://ng.investing.com/news/stock-market-news/tang-capital-management-kevin-tang-buy-222k-boundless-bio-stock-93CH-2597755", "source_name": "Investing.com Nigeria", "published_at": "2026-07-14T00:39:59", "published_display": "14 Jul 2026 00:39", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Boundless Bio Inc For: 13 July By Investing.com", "summary": "This article from Investing.com reports the filing of a Form 4 for Boundless Bio Inc. for July 13. The brief announcement provides no specific details from the Form 4 itself but mentions that the company's stock symbol is BOLD, which was down 0.82% at the time of publication.", "url": "https://ng.investing.com/news/stock-market-news/form-4-boundless-bio-inc-for-13-july-93CH-2597757", "source_name": "Investing.com Nigeria", "published_at": "2026-07-14T00:16:00", "published_display": "14 Jul 2026 00:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Teleflex Incorporated (TFX) Stock Analysis: Unpacking a 32.3% Revenue Growth in the Healthcare Sector", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxPQ3B5MlVsTlBhcXdmUVllazV2SWFHTmRudHVNdFY3RUYtR1FTXzNIV1VYODF0bTMyVThkOE1LZC11TGN2dUxBZzRPTDQxUDVDdF9PWW5VUk1rZVJkdXRjbTQ2MU1wa3BtejZ5NUhWY1dQLUZLS3duak1fMzIxcnNwUmc4X3N5Q1JXMFNQY1J0ZVd5aHF4NHVUQkpnNlNUU1VWcVljNjhGbkFicUNyOXktR0lZWkVxT09oU0VQZnZObG5RMkJDWHh4czRrUktNZFNrZVhKWnF1YTZ2ZmVzTG14WG1n?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-07-13T09:24:17+00:00", "published_display": "13 Jul 2026 09:24", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Goldman Sachs Just Made 4 Bold Calls: 2 Sells, 1 Buy, and a $2,159 Price Target On This Popular Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxNY0oxb0FPcWtTZ241c3B5bllDRnpTeGpMZEZsMFJVcHpSd1VIYTdMbWpURkRIeXgyLWt4RjJ6aTY4Rm5md2ZmTDFVZ3FSb1hqV0RpNElEaUphTFF4a0MxYTJLeFNTbW5iUjhBZ2tOSjJuNjBLSzhuRC1wcERUblNmOEg4dE1HQ1k1RElOUzVmeEFVWGg5ekFDR0JjVDdETm8xdi1fbWFSQmc1ekx3LU5vWTU5RDMxUFU1aFVoX1ZQNGlDNktyLS1kWENCTEVTZWlETlBZRkQ1TQ?oc=5", "source_name": "24/7 Wall St.", "published_at": "2026-07-11T04:02:16+00:00", "published_display": "11 Jul 2026 04:02", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This solar stock could surge 80% on bold plan to turn your home into an AI data center, says Wells Fargo", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxQVTZvUUZWNVF6NlFXbFp4UWJNdE82NmVZM2I0bHg3ZTNQX256clZrZFZJNk5FYVg4MFB4MHdHWWQyOHJkRGxwNHEyNXN1eWNBRzFlN0ltREpWZFY3R1dPeWF5cjRLeGtWLTVtTGZ1M1k1YkRhYVNyblNZYkwyUHdndHdxSDBLMUpOY1B1aTQ0T3pPTXdTenVR?oc=5", "source_name": "CNBC", "published_at": "2026-07-09T18:21:39+00:00", "published_display": "09 Jul 2026 18:21", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "My Bold Prediction for This Stock Through 2030", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNUnVfQXBpRVNwOWxPaFNOU2x5NHBJUlhBYjVBMkRSUWxIWWtCY2s0LWNUMzNDR205Mzl4MDNJUG9CTks5ODFmWEgyZmVFd1pXM0lad1R6VkVtZElYNzRhMDNRMkpnc0lJWmx6Q3dTYkxTdzJKWVQySmJVSXMyWDQ5aEo1MzRtajdvYTlIcVl2VjVVSEZa?oc=5", "source_name": "24/7 Wall St.", "published_at": "2026-07-09T17:00:17+00:00", "published_display": "09 Jul 2026 17:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ten percent owner of Boundless Bio (NASDAQ: BOLD) adds shares", "summary": "Entities associated with Tang Capital Partners, a ten percent owner of Boundless Bio (NASDAQ: BOLD), purchased a total of 57,210 shares of common stock through open-market transactions between July 6 and July 8, 2026. These shares were bought at weighted-average prices ranging fr", "url": "https://www.stocktitan.net/sec-filings/BOLD/form-4-boundless-bio-inc-insider-trading-activity-8bb28b30217d.html", "source_name": "Stock Titan", "published_at": "2026-07-09T01:10:24", "published_display": "09 Jul 2026 01:10", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kevin Tang\u2019s Tang Capital buys $141,864 in Boundless Bio (BOLD) By Investing.com", "summary": "Kevin Tang and Tang Capital Management LLC increased their investment in Boundless Bio (NASDAQ:BOLD) by purchasing $141,864 worth of shares between July 6 and July 8, 2026. These transactions occurred as Boundless Bio's stock has seen a significant surge, despite an InvestingPro ", "url": "https://ca.investing.com/news/stock-market-news/kevin-tangs-tang-capital-buys-141864-in-boundless-bio-bold-93CH-4726272", "source_name": "Investing.com Canada", "published_at": "2026-07-09T00:13:02", "published_display": "09 Jul 2026 00:13", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Texas Instruments Stock Is Running On A Bold Promise", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxNNl9ZaEgyU1dlOGJ6THFxX2JtWlZRS1h2WEtCcDZ2UmR3dmpHUEtCcmt0aVA2WHl6bFBlSkpSOW9uaUhPTVdHRm1vM2tzckxCRjc0RGtGcndKem5VRDBvWmlydkZDVXM4a3VENjlqcTZhNVVXbzkzVzFRRGdQVkItVUVkVWpGQm1NX1Rqb01ieEE2aXhQdDdEa2MzTUh5MkJ5QjBSQWF1VG4zYzNIR1lyOWtR?oc=5", "source_name": "Trefis", "published_at": "2026-07-08T07:00:00+00:00", "published_display": "08 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Boundless Bio Inc For: 6 July By Investing.com", "summary": "This article from Investing.com announces the filing of Form 4 for Boundless Bio Inc for July 6th. Form 4 is a document that must be filed with the U.S. Securities and Exchange Commission (SEC) by company insiders, such as officers, directors, and significant shareholders, within", "url": "https://ca.investing.com/news/stock-market-news/form-4-boundless-bio-inc-for-6-july-93CH-4721859", "source_name": "Investing.com Canada", "published_at": "2026-07-06T22:11:15", "published_display": "06 Jul 2026 22:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ARCH funds, insiders trade 16,000 Boundless Bio (BOLD) shares", "summary": "Entities associated with ARCH Venture funds and investment committee member Kristina Burow conducted insider trading activities involving Boundless Bio (BOLD) shares. On July 1, 2026, 16,000 shares were acquired through a cashless stock option exercise at $1.03 per share and subs", "url": "https://www.stocktitan.net/sec-filings/BOLD/form-4-boundless-bio-inc-insider-trading-activity-a7effd86f512.html", "source_name": "Stock Titan", "published_at": "2026-07-06T22:11:14", "published_display": "06 Jul 2026 22:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arch venture funds sell $39,840 in Boundless Bio stock", "summary": "Several ARCH Venture Funds and Partners entities sold 16,000 shares of Boundless Bio, Inc. (NASDAQ:BOLD) common stock for $39,840 on July 1, 2026. This transaction followed a cashless exercise of stock options, with the shares acquired at $1.03 and immediately sold at $2.49. The ", "url": "https://www.investing.com/news/insider-trading-news/arch-venture-funds-sell-39840-in-boundless-bio-stock-93CH-4777779", "source_name": "Investing.com", "published_at": "2026-07-06T22:11:14", "published_display": "06 Jul 2026 22:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "16K Boundless Bio (BOLD) shares sold by ARCH funds post-exercise", "summary": "ARCH-affiliated entities reported a cashless stock option exercise and subsequent sale of 16,000 Boundless Bio (BOLD) shares. The transaction, tied to director Kristina Burow's compensation, involved exercising options at $1.03 per share and selling the shares at $2.49 per share.", "url": "https://www.stocktitan.net/sec-filings/BOLD/form-4-boundless-bio-inc-insider-trading-activity-6b853a676322.html", "source_name": "Stock Titan", "published_at": "2026-07-06T22:11:14", "published_display": "06 Jul 2026 22:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of: Element Solutions Inc. (NYSE \u2013 ESI), Boundless Bio Inc. (Nasdaq \u2013 BOLD), Nuvalent, Inc. (Nasdaq \u2013 NUVL), Dana Incorporated (NYSE \u2013 DAN)", "summary": "Brodsky & Smith LLC is investigating the proposed acquisitions of Element Solutions Inc. (NYSE \u2013 ESI), Boundless Bio Inc. (Nasdaq \u2013 BOLD), Nuvalent, Inc. (Nasdaq \u2013 NUVL), and Dana Incorporated (NYSE \u2013 DAN). The law firm reminds investors that there is no cost or financial obligat", "url": "https://www.globenewswire.com/news-release/2026/07/06/3322626/0/en/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-element-solutions-inc-nyse-esi-boundless-bio-inc-nasdaq-bold-nuvalent-inc-nasdaq-nuvl-dana-inco.html", "source_name": "GlobeNewswire", "published_at": "2026-07-06T16:11:14", "published_display": "06 Jul 2026 16:11", "sentiment": "negative", "sentiment_pct": 33, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TANG CAPITAL MANAGEMENT LLC Acquires Significant Stake in Boundl", "summary": "TANG CAPITAL MANAGEMENT LLC has acquired 2,533,845 shares of Boundless Bio Inc (NASDAQ: BOLD) for $2.60 per share, establishing a 0.33% position in the biotechnology company. Boundless Bio Inc is a clinical-stage oncology company developing cancer therapeutics targeting extrachro", "url": "https://www.gurufocus.com/news/8944626/tang-capital-management-llc-acquires-significant-stake-in-boundless-bio-inc", "source_name": "GuruFocus", "published_at": "2026-07-04T01:09:21", "published_display": "04 Jul 2026 01:09", "sentiment": "positive", "sentiment_pct": 64, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Boundless Bio Inc For: 2 July By Investing.com", "summary": "This article from Investing.com is a standard financial news brief announcing a \"Form 4\" filing for Boundless Bio Inc. dated July 2nd. It does not provide further details about the filing but is presented within a typical Investing.com layout, including market data and related ne", "url": "https://uk.investing.com/news/stock-market-news/form-4-boundless-bio-inc-for-2-july-93CH-4756062", "source_name": "Investing.com UK", "published_at": "2026-07-03T11:10:45", "published_display": "03 Jul 2026 11:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kevin Tang buys $268,880 of Boundless Bio (NASDAQ:BOLD) shares By Investing.com", "summary": "Kevin Tang and Tang Capital Management LLC, significant owners of Boundless Bio (NASDAQ:BOLD), acquired common stock worth $268,880 through various transactions between June 30 and July 2, 2026. These purchases occurred at weighted-average prices ranging from $2.49 to $2.54, as t", "url": "https://m.za.investing.com/news/stock-market-news/kevin-tang-buys-268880-of-boundless-bio-nasdaqbold-shares-93CH-4354980?ampMode=1", "source_name": "Investing.com South Africa", "published_at": "2026-07-03T00:39:34", "published_display": "03 Jul 2026 00:39", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Boundless Bio (BOLD) major holder buys 107,463 Common shares", "summary": "Entities affiliated with Kevin Tang, a major holder in Boundless Bio (BOLD), purchased 107,463 shares of common stock through open-market transactions between June 30 and July 2, 2026. The purchases were made at prices ranging from $2.49 to $2.60 per share, increasing their total", "url": "https://www.stocktitan.net/sec-filings/BOLD/form-4-boundless-bio-inc-insider-trading-activity-d430b16ea5af.html", "source_name": "Stock Titan", "published_at": "2026-07-02T23:39:34", "published_display": "02 Jul 2026 23:39", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tang Capital entities disclose 2.25M Boundless Bio (BOLD) shares in Form 3 filing", "summary": "Entities affiliated with Tang Capital, managed by Kevin Tang, have disclosed an initial beneficial ownership of 2,247,512 shares of Boundless Bio (BOLD) common stock. This information was revealed in a Form 3 filing, which serves as an initial statement of ownership rather than a", "url": "https://www.stocktitan.net/sec-filings/BOLD/form-3-boundless-bio-inc-initial-statement-of-beneficial-ownership-ef28833a944b.html", "source_name": "Stock Titan", "published_at": "2026-06-30T21:40:22", "published_display": "30 Jun 2026 21:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tang Capital Management acquires $714,768 of Boundless Bio stock", "summary": "Tang Capital Management LLC and its manager, Kevin Tang, acquired 286,333 shares of Boundless Bio (NASDAQ:BOLD) common stock worth $714,768 between June 25 and June 29, 2026. These transactions, at prices ranging from $2.47 to $2.56 per share, increase their total indirect owners", "url": "https://www.investing.com/news/insider-trading-news/tang-capital-management-acquires-714768-of-boundless-bio-stock-93CH-4766743", "source_name": "Investing.com", "published_at": "2026-06-30T10:09:43", "published_display": "30 Jun 2026 10:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tang Capital-affiliated funds boost Boundless Bio (BOLD) stake with 286K-share buy", "summary": "Funds affiliated with Tang Capital increased their stake in Boundless Bio (BOLD) by purchasing 286,333 shares between June 25-29, 2026. These open-market purchases were made at weighted-average prices generally ranging from $2.40 to $2.60 per share, through various Tang Capital l", "url": "https://www.stocktitan.net/sec-filings/BOLD/form-4-boundless-bio-inc-insider-trading-activity-b74456645899.html", "source_name": "Stock Titan", "published_at": "2026-06-30T00:10:40", "published_display": "30 Jun 2026 00:10", "sentiment": "positive", "sentiment_pct": 72, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tang Capital Management acquires $714,768 of Boundless Bio stock By Investing.com", "summary": "Tang Capital Management LLC, led by Kevin Tang, recently acquired 286,333 shares of Boundless Bio (NASDAQ: BOLD) common stock for $714,768 through multiple transactions between June 25 and June 29, 2026. These purchases were made at prices ranging from $2.47 to $2.56 per share, i", "url": "https://m.za.investing.com/news/stock-market-news/tang-capital-management-acquires-714768-of-boundless-bio-stock-93CH-4348868?ampMode=1", "source_name": "Investing.com South Africa", "published_at": "2026-06-30T00:10:40", "published_display": "30 Jun 2026 00:10", "sentiment": "positive", "sentiment_pct": 62, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tang-linked entities report 11.3% stake in Boundless Bio (NASDAQ: BOLD)", "summary": "A Schedule 13G filing reveals that Tang Capital Management, Kevin Tang, and affiliated entities collectively beneficially own 11.3% of Boundless Bio (NASDAQ: BOLD), representing 2,533,845 shares. This passive investment indicates shared voting and dispositive power among the invo", "url": "https://www.stocktitan.net/sec-filings/BOLD/schedule-13g-boundless-bio-inc-passive-investment-disclosure-5-655d03c9ccae.html", "source_name": "Stock Titan", "published_at": "2026-06-30T00:10:40", "published_display": "30 Jun 2026 00:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Boundless Bio Inc For: 29 June By Investing.com", "summary": "This article from Investing.com reports the filing of a Form 4 for Boundless Bio Inc. dated June 29. It provides no further details beyond the title and a stock symbol (BOLD) with a slight price drop. The content primarily consists of market data and unrelated news headlines.", "url": "https://za.investing.com/news/stock-market-news/form-4-boundless-bio-inc-for-29-june-93CH-4348871", "source_name": "Investing.com South Africa", "published_at": "2026-06-30T00:10:40", "published_display": "30 Jun 2026 00:10", "sentiment": "negative", "sentiment_pct": 40, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Boundless Bio, Inc. \u2013 NASDAQ:BOLD", "summary": "The article provides financial information for Boundless Bio, Inc. (NASDAQ: BOLD), specifically focusing on its enterprise value to revenue forward metric. It appears to be a financial data page from TradingView, offering an overview of the company's financials, news, and technic", "url": "https://www.tradingview.com/symbols/NASDAQ-BOLD/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-29T17:10:29", "published_display": "29 Jun 2026 17:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Boundless Bio, Inc. \u2013 NASDAQ:BOLD", "summary": "This article provides the forward price-to-sales ratio for Boundless Bio, Inc. (NASDAQ: BOLD), as listed on TradingView. It indicates that the NASDAQ market was closed at the time the data was presented, with no trades reported. The content is primarily a data point surrounded by", "url": "https://www.tradingview.com/symbols/NASDAQ-BOLD/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-29T06:41:56", "published_display": "29 Jun 2026 06:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Boundless Bio, Inc. \u2013 NASDAQ:BOLD", "summary": "This article focuses on the enterprise value to EBITDA forward for Boundless Bio, Inc. (NASDAQ: BOLD). It appears to be a placeholder or a stub page from TradingView, indicating financial data for the company. The page structure suggests it's part of a larger financial data servi", "url": "https://www.tradingview.com/symbols/NASDAQ-BOLD/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T13:39:55", "published_display": "28 Jun 2026 13:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Serapha Bio, Inc. entered into a definitive merger agreement to acquire Boundless Bio, Inc. in a reverse merger transaction.", "summary": "Serapha Bio, Inc. has entered into a definitive merger agreement to acquire Boundless Bio, Inc. in a reverse merger transaction. This deal will result in Serapha equity holders owning approximately 96.31% of the combined company, with Boundless Bio equity holders retaining 3.69%.", "url": "https://www.marketscreener.com/news/serapha-bio-inc-entered-into-a-definitive-merger-agreement-to-acquire-boundless-bio-inc-in-a-rev-ce7f5fdbdb8ef020", "source_name": "www.marketscreener.com", "published_at": "2026-06-26T22:40:52", "published_display": "26 Jun 2026 22:40", "sentiment": "positive", "sentiment_pct": 67, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BOLD Stock Alert: Halper Sadeh LLC is Investigating Whether Boundless Bio, Inc. is Obtaining a Fair Price for its Shareholders", "summary": "Halper Sadeh LLC, an investor rights law firm, is investigating the proposed merger of Boundless Bio, Inc. (NASDAQ: BOLD) with Serapha Bio, Inc. The firm is examining whether Boundless Bio shareholders are receiving a fair price, as they are expected to own only about 3.7% of the", "url": "https://www.marketscreener.com/news/bold-stock-alert-halper-sadeh-llc-is-investigating-whether-boundless-bio-inc-is-obtaining-a-fair-ce7f5fdad18df12d", "source_name": "marketscreener.com", "published_at": "2026-06-26T22:40:52", "published_display": "26 Jun 2026 22:40", "sentiment": "negative", "sentiment_pct": 36, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Boundless Bio Inc. Actuals & Estimates (NASDAQ:BOLD)", "summary": "This article provides an overview of Boundless Bio, Inc. (NASDAQ: BOLD), detailing its financial actuals and estimates, stock performance, and analyst forecasts. It covers the current stock price, historical highs and lows, market capitalization, upcoming earnings reports, and te", "url": "https://www.tradingview.com/symbols/NASDAQ-BOLD/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T20:40:20", "published_display": "26 Jun 2026 20:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BOLD Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides an overview of Boundless Bio, Inc. (BOLD) stock, including its current price, price target, analyst ratings, and financial performance. It highlights that analysts have a maximum price target of $4.00 for the stock, and the company has shown significant pric", "url": "https://www.tradingview.com/symbols/NASDAQ-BOLD/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T06:39:40", "published_display": "26 Jun 2026 06:39", "sentiment": "positive", "sentiment_pct": 70, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Are TECH, APGE, BOLD, REFI Obtaining Fair Deals for their Shareholders?", "summary": "Halper Sadeh LLC, an investor rights law firm, is investigating several companies\u2014Bio-Techne Corporation (TECH), Apogee Therapeutics, Inc. (APGE), Boundless Bio, Inc. (BOLD), and Chicago Atlantic Real Estate Finance, Inc. (REFI)\u2014for potential violations of federal securities laws", "url": "https://www.tradingview.com/news/prnewswire:764921ceb76dc:0-are-tech-apge-bold-refi-obtaining-fair-deals-for-their-shareholders/", "source_name": "TradingView", "published_at": "2026-06-25T18:09:58", "published_display": "25 Jun 2026 18:09", "sentiment": "negative", "sentiment_pct": 30, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Boundless Bio, Serapha Bio Sign Merger Deal With $230 Million Private Placement", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/boundless-bio-serapha-bio-sign-115841859.html", "source_name": "MT Newswires", "published_at": "2026-06-23T11:58:41+00:00", "published_display": "23 Jun 2026 11:58", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BOLD Stock Is Up 90% \u2014 Here's What's Behind The Biggest Rally In Company History", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxPNGExYlpRZDZkRkxEbWNMUjFmZ0VocGV3cERwcnFRSW92RFYwOEZxb0tSTXdkRzZMbWwzbGRlckdDRmJ1bUNjRjJPZFNBTXZsZ1IzR3hQdTlrNU41OFBDRU1SUlZxNWZhNnV4WlY3RE1YQVgzbGFNVWNSSTZyaEhFdHY0SHp0cWRMMmVEYnc2VHR0YUEwTUZ4RmpJZ0w?oc=5", "source_name": "Stocktwits", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Boundless Bio and Serapha Bio Announce Merger Agreement and $230 Million Concurrent Private Placement", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Manila Times", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Boundless Bio to Merge with Serapha Bio, Restructure Operations", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOV2RhTFpQX25Qa2NTY3hBMkxfakVMOWxiY1hGbUVpaFY3MXptcEZzLVNXWF91OFVkWG5pQ2tXODlKbmNnN3Z4eWE3RC1Gbk1KMGp0T29sd28ydi10MUVGSll3SlR0Y054clZOa25VUjl5LVplaDkzd3ZWRXJKbENaTGJSMngyMzRDRV9na1hNekxpazdZR3BobnlMMkZxNUdKMkdiME1FQWhGNWNIRHNkSExRczA?oc=5", "source_name": "TipRanks", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Macy's Stock Outlook Improves as Bold New Chapter Gains Traction", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxQZklheFN5ZF9LMEw4T1hOcEd2cDRTeEdkYkl4S05HMXZnSFNrUFVYYTA4cl9vV3N6MUFnREphcGNuV3JBNUtuVzRpRlZJV1BJeDVENlJPbDNfRVAxcUlNejF2X0l3cE04NnpLTVR6aUlkVjN1MXNKMnQ5ZVctbU92SmtsTUY2XzB1S2d6UTAxN25SZmdabEtFcUdOLXdPOG8?oc=5", "source_name": "Market source", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[8-K] Boundless Bio, Inc. Reports Material Event", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxOSTNaN2J1RnQtS0VJZHR3TzdFaEhodGhfckpxMTdlcXZKVnR1MjVuR3FGQWxfay1nMjBfM0NiU2dTUlhWNUN0c3FwZGQzbklwOVk1aTM0RFVuRXZfZDRJTnNobDhLcFBSQ0hnM1UwbFNyNDd5aGM3Z0lsVEhNT2NnZFJoUjNycDJtdHpndG5kSHJ5OHNhQ19jWWQyR3JrR19xcEE5UzNMSjRMQQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology Stock Rises 19% in 3 Months: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQM0ExNm9zZVBVMzB2cTFsYkhQeDJyeUV5Y1lSdWdsa2V2STFTSFBkYVlrRDJaUmE0bjZVLUxmZEh1UkFPbndtdWVDWmJBcEJaSmpTSlN4RkFkdF9EYkhFUXh3YWxqREkxRllfRXE0bFVuSkMwaExFNmk0UmNoa2R2NmQyb0p1N2pudENMMGMwWmVGT0J5SUxfeE5hT2hpUms1NHR4NzY1VWpNQVFYUWJkUnN3?oc=5", "source_name": "TradingView", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UNH stock jumps on Q1 earnings beat and raised guidance to $18.25+", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPTEprdzNMNGZxdkg5Wll5MTlvS1dheXQybm14TERTcGVzcHQzY0llOEpTa0dpZ1hGdHVyNWZ2cFFiWmZRdkl1aUp4YVlTMVJxSDRzaEdzRFB1cW93QzdhSmNxcEZDMWhGX2F0ODJFcjY1Mk1kMVhLNnVJSUhVMHZpRjRtTHo2cXBvbVJ3a05SWlJNMUdrSzFPbA?oc=5", "source_name": "eciks.org", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "eBay Stock Reaches New All-Time Highs Following Ryan Cohen's Bold Comment - EPS Miss Report", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxQZmFrSU42aXpoYnZFeWVEc091a3JkeHZGbFBoZ3lQOC04MmYtUjN5NEkxQXVkWFFqaDIwN3VSQVFhRFlDUWU0dVFNa3JrNmpVbmZCazZqWEZVRVQ5UFgwTzEzUzYtTFVHcW1JVngtZEtFUmI0X2o0clRaMmNWdE5GTEo1Q3drMWpMU2puTjJZUThmRW9xTjlqUjNNQmQ2N3R6VlZUbEFKem5UUHFSUmRrOWlZSzh1dw?oc=5", "source_name": "lwvtexas.org", "published_at": "2026-05-17T07:00:00+00:00", "published_display": "17 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PDS BIOTECHNOLOGY ($PDSB) Releases Q1 2026 Earnings | PDSB Stock News", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxOcEdqLWM1SmVuNHpvZ2poNU5mOFppaWNtUi1IQVRHTmgxLUpyZHdUSDRnekdzMmVFQzFzUGo2RjlYenpCaTlfcUZhMm1yTzRwWUxnM01WY0libmxIVXNSM3RtMGxMY2RURTdMVW96bGU0SGZXRkE2SnVQdVNNUWw5RWtJQVJMX2pQQnRBRHBKMlRCUDct?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Boundless Bio Reports First Quarter 2026 Financial Results and Business Highlights", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/boundless-bio-reports-first-quarter-110000504.html", "source_name": "GlobeNewswire", "published_at": "2026-05-08T11:00:00+00:00", "published_display": "08 May 2026 11:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GE HealthCare (NASDAQ:GEHC) Posts Better-Than-Expected Sales In Q1 CY2026 But Stock Drops", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxOUjRRb0hlcHlOazlmelFaVVJSQWNnRmExZVBEQW1HMmVLTjNyU3d4WElsU05hdGlfYWFSY0twMTNWOVVCY0h4U2dYQ19BQl9pa3o0NWNBLW50WmFsSEVHdmJFV3JabnN5MFZpUWZabjZzY2tjMUtxbndONm9DS3NxTUp3Qjg2dWZnMDR2NXZ2eU80MWhSODVKdVgxZVJ6TWs3RFpCaDFqMXVtVkhmRVlOcWtqYUV1X1FPcGpfdERhRmwzdkZDaWxtSnJnd25Oam4yTnFHTFBkZi0tM1BZdkE?oc=5", "source_name": "StockStory", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott is the most oversold healthcare stock as Q1 earnings roll on (XLV:NYSEARCA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOc2thQjFpazgwaFRfS3NjVXhlTkdFWHNFb240S0Z6akFtQXFIMmFmaXZnQ1A3OFVCQW9DT25OLVBQdGN5Yk52Mk9yUFlSX19ZS3FRTjZoR05zc2FVc25pVHQ0TDVHT2JmVnJabGNCREdLT2stV0IzLVdHWXpFZGU3V1NnVGhYbFRzNURVek41TVRmLWZQZTFYUkc4aXM0a1cwTkNFYTBfVnQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology Stock Declines More Than 9% in a Month: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxNTTJZRVF4TFNBb3BhMW9VUnBnMVZhenZLNlZJY3Ryc3pGZ3dhZXBDY3pId0I5NFdmVTdiR2EyNXNBZFFuQ1M2M3pUTlRZdXJkbGxaT29mWm4wTG5fU2RtV1hIZWRwZUVNb3BEbTZKX3NPRV9mZVpiY3JBZDdMSDRveW1Jb0lIVmRKLVlidA?oc=5", "source_name": "Market source", "published_at": "2026-03-18T07:00:00+00:00", "published_display": "18 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAJBVV95cUxPV1hqSFhQM3VfYlNsdldfeVQ1dEdNNzI3S1RTaFJNSThrOXlPSWpMTlR5WWVxNnNsTzhTVGVvTE94R18wa1A0OUdFczBlcTIzeUFBZUt6VVJJMjNqNks3dmRUSzB4cE40anpNekJwUXAwcTFEcVh4QVZCYURXY2w4b2thdk5KZ3ZJMnI1REJObXo5UDdISXVCU1Z2ZVZoVmJpbnEzaDVWVmpGQVNFZzRXYnp0SWRRWWZGSnZnWlJ4aEloNmJBNGRMVFRjb3ZRbmV3QXF5S0pvTV9xNnpaMWV1Z1ZtM3lPdV9RcEdURHlfZFphdjlicEJndW0ybHNBa205?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-07-13T03:32:00+00:00", "published_display": "13 Jul 2026 03:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 95, "total_relevant": 66, "sentiment_summary": {"positive": 22, "negative": 7, "neutral": 37, "score": 55, "total": 66, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 78, "events": [{"event": "general", "label": "Market update", "weight": 18.3, "count": 32}, {"event": "earnings", "label": "Earnings", "weight": 11.15, "count": 21}, {"event": "deals", "label": "Deals and strategy", "weight": 4.95, "count": 9}, {"event": "guidance", "label": "Guidance", "weight": 1.1, "count": 2}, {"event": "analyst", "label": "Analyst action", "weight": 1.1, "count": 2}], "positive_events": 22, "negative_events": 7}, "market_context": {"has_market_context": true, "latest_close": 2.41, "latest_week": "2026-07-10", "one_week_move": -3.6, "four_week_move": 70.9, "twelve_week_move": 52.5, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 1.472861, "market_dynamics_buy_signal": false, "relative_strength": 57.907308, "fair_value_gap": -13.1, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 51.8387, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-3.6% over one week, +70.9% over four weeks, trend active, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 63, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 8}, {"label": "TradingView", "count": 8}, {"label": "Market source", "count": 7}, {"label": "Investing.com", "count": 3}, {"label": "Investing.com South Africa", "count": 3}, {"label": "Finbold", "count": 2}, {"label": "Investing.com Nigeria", "count": 2}, {"label": "24/7 Wall St.", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 58}, {"label": "Industry context", "count": 8}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 32}, {"label": "Earnings", "count": 21}, {"label": "Deals and strategy", "count": 9}, {"label": "Guidance", "count": 2}, {"label": "Analyst action", "count": 2}]}, "insights": [{"label": "Weighted tone", "value": "55/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "78/100 classification confidence."}, {"label": "Company focus", "value": "58", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "4", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-3.6% over one week, +70.9% over four weeks, trend active, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Jim Cramer just revealed his \u2018favorite stock\u2019"}], "updated_at": "2026-07-17T00:24:07.775181+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}